Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fenretinide in Insulin Resistance and NAFLD
NCT00546455Phase 2Suspended
- Sponsor
- University of California, San Diego
- Start
- Dec 2007
- Primary completion
- Jan 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fenretinide in insulin resistance (IR), sponsored by University of California, San Diego. Started Dec 2007; status: suspended.
02
Drugs
fenretinide
03
Conditions
insulin resistance (IR)
Beyond the preview
Go deeper on NCT00546455.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00546455.